Please Wait

Applying Filters...

CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
USDMF
Table View

Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 13 USDMF, 14 CEP/COS, 6 EU WC, 1 KDMF, 1 NDC API, 12 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers, 35 FDA Orange Book, 70 Europe, 2 Canada, 8 Australia, 52 South Africa, 48 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 30MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Fillers, Diluents & Binders, 2 Parenteral, 1 Co-Processed Excipients, 1 Taste Masking

DIGITAL CONTENT

1 News #PharmaBuzz

1 News #PharmaBuzz

GLOBAL SALES INFORMATION

35 Regulatory FDF Prices

35 Regulatory FDF Prices

MARKET PLACE

12 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
25/04/2025	ACS DOBFAR SPA	Italy	ACS DOBFAR SPA	13205	CEFUROXIME SODIUM (STERILE BULK)	1998-04-30	Active	II	N/A
25/04/2025	Aurobindo Pharma Limited	India	AUROBINDO PHARMA LTD	18885	CEFUROXIME SODIUM (STERILE) USP	2005-10-01	Inactive	II	N/A

Contact us
to update this info

CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers

13 USDMF

14 CEP/COS

6 EU WC

1 KDMF

1 NDC API

12 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers

35 FDA Orange Book

70 Europe

2 Canada

8 Australia

52 South Africa

48 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 30MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 Actylis

1 Kerry

1 Microlex e.U

1 Pluviaendo

1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Fillers, Diluents & Binders

2 Parenteral

1 Co-Processed Excipients

1 Taste Masking

DIGITAL CONTENT

1 News #PharmaBuzz

GLOBAL SALES INFORMATION

35 Regulatory FDF Prices

MARKET PLACE

12 APIs

5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM

1 Others

ANALYTICAL

1 BioAnalytical Methods

Filters

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons